Synthego Sale to Perceptive Set to Close in July
26 Jun 2025 //
PR NEWSWIRE
Synthego & AstraZeneca Sign CRISPR Gene Editing Enzyme Deal
13 Jan 2025 //
CONTRACTPHARMA
Synthego Announces Invalidation of Agilent Patents in CRISPR Dispute
19 May 2023 //
PR NEWSWIRE
Synthego Opens State-of-the-Art GMP Synthesis Facility
12 May 2023 //
CONTRACT PHARMA
Synthego Unveils CRISPR Discovery Partners to Streamline Drug Research
17 Mar 2023 //
CONTRACT PHARMA
Synthego Launches Engineered Cell Libraries to Validate Targets
02 Aug 2022 //
BUSINESSWIRE
Synthego Expands Capabilities of Halo Platform with Next-Gen Mfg Facility
26 Jul 2022 //
BUSINESSWIRE
With $200M, Synthego wants to become the manufacturing bedrock for CRISPR
17 Feb 2022 //
ENDPTS
Synthego`s CRISPR platform enables faster ID of potential Coronavirus treatment
18 Oct 2020 //
EUREKALERT
Synthego adds $100M from RA, Wellington, 8VC of `virtualizing biology`
26 Aug 2020 //
ENDPTS